搜索

quanfu quanfu

Product Center

Homepage
/
News
/
Company news
/
Successfully selected as a national open topic!

Successfully selected as a national open topic!

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2023-11-15
  • Views:

(Summary description)Recently, after evaluation by experts from the Drug Evaluation Center of the National Medical Products Administration, Ab&B Bio Tech CO., LTD. JS's "Research on Safety Evaluation of Tetravalent Influe

Successfully selected as a national open topic!

(Summary description)Recently, after evaluation by experts from the Drug Evaluation Center of the National Medical Products Administration, Ab&B Bio Tech CO., LTD. JS's "Research on Safety Evaluation of Tetravalent Influe

  • Categories:Company news
  • Author:
  • Origin:
  • Time of issue:2023-11-15 15:17
  • Views:
Information
Recently, after evaluation by experts from the Drug Evaluation Center of the National Medical Products Administration, Ab&B Bio Tech CO., LTD. JS's "Research on Safety Evaluation of Tetravalent Influenza Virus Subunit Vaccines after Market Launch" project has been successfully selected as a national open research topic.
 
 
It is reported that the project was led by Tao Hang, the head of drug vigilance and director of marketing medicine at Ab&B Bio Tech CO., LTD. JS. Under the careful guidance of Jiangsu Province Drug Adverse Reaction Monitoring Center and other units, it was jointly completed by multiple institutions such as Jiangsu Province Drug Adverse Reaction Evaluation Center, Jiangsu Province Center for Disease Control and Prevention, and Nanjing Medical University.
The aim of this project is to evaluate the safety of the quadrivalent influenza virus subunit vaccine in a large-scale population aged 3 and above, and to explore new methods for dynamic monitoring of vaccine safety after market launch. In addition, a large-scale digital information collection method will be used to explore models suitable for China's national conditions for drug surveillance work at the beginning of new drug launch, helping to promote China's vaccine regulatory system towards higher maturity goals.
Scan the QR code to read on your phone
Previous: The kickoff meeting for the Phase I clinical trial of freeze-dried human rabies vaccine (human diploid cells) was successfully held
Next: Ab&B Bio-Tech CO.,LTD.JS The delegation went to Brazil, Uruguay, Chile, and Spain to carry out multinational exchange and cooperation activities
Previous: The kickoff meeting for the Phase I clinical trial of freeze-dried human rabies vaccine (human diploid cells) was successfully held
Next: Ab&B Bio-Tech CO.,LTD.JS The delegation went to Brazil, Uruguay, Chile, and Spain to carry out multinational exchange and cooperation activities

Relevant information

Have a project？Get a touch!

Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio

Contact

E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City

Quick view

Follow us

Copyright © 2022 Ab&B Bio-Tech CO.,LTD.JS All Rights Reserved.   Powered by:www.300.cn
Verification 苏ICP备16005775号-1
Search